ORAL02.02: Efficacy and Safety of Everolimus in Advanced, Progressive, Nonfunctional Neuroendocrine Tumors (NET) of the Lung: RADIANT-4 Subgroup Analysis: Topic: Medical Oncology

Yao, J.; Fazio, N.; Buzzoni, R.; Delle Fave, G.; Tesselaar, M.; Wolin, E.; Van Cutsem, E.; Tomassetti, P.; Strosberg, J.; Voi, M.; Pacaud, L.; Ridolfi, A.; Singh, S.; Pavel, M.; Kulke, M.

Journal of Thoracic Oncology 11(11s): S253

2016

1556-1380

10.1016/j.jtho.2016.09.011

https://eurekamag.com/research/060/050/060050453.php